Pharmacokinetics and Relative Bioavailability of Metformin Extended-release Tablets in Healthy Volunteers

Wei-Lan LI,Xiao-Dong LIU,Lin XIE,Xiang-Yu ZHENG

DOI: https://doi.org/10.3969/j.issn.1673-7806.2006.02.002

2006-01-01

Abstract:AIM To evaluate the pharmacokinetics and relative bioavaibility of metformin extended-release tablets (test) to common tablets(reference). METHOD An open-label,randomized and crossover clinical trial recruited 20 healthy volunteers,who were equally randomized to give either a single oral dose(1000 mg) or a multiple oral dose (1000 mg·d -1)of reference and test metformin. The plasm concentrations of metformin were measured using RP-HPLC and the pharmacokinetic parameters were estimated. RESULT The pharmacokinetic parameters of test and reference metformin were as follows. Single dose:AUC_ 0-24(11.95±2.62) vs (10.72±2.23) μg·h -1·ml -1,C_ max(1.50±0.22) vs (2.34±0.30) μg·ml -1,T_ max(3.38±0.8) vs (1.61±0.32) h,t_ 1/2(4.94±0.47) vs (3.20±0.38) h. The relative bioavailability of test to reference metformin was (111.5±8.3)%. Multiple doses;AUC_ ss(15.04±3.01) vs (14.51±2.69) μg·h -1·ml -1,C_ max(1.68±0.25) vs (1.60±0.26) μg·ml -1,C_ min(0.15±0.03) vs (0.12±0.04) μg·ml -1,Cav(0.62±0.13) vs (0.61±0.11) μg·ml -1,T_ max(3.61±0.60) vs (1.88±0.38) h. The relative bioavailability of test to reference metformin was (103.6±9.2)%. CONCLUSION The reference metformin is bioequivalent to the test,and the test metformin tablets have extended release characteristics.